Treatment of levodopa-induced dyskinesias
AssigneeNorthwestern University
InventorsDalton James Surmeier, Weixing Shen, Zhong Xie
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for the treatment and prevention of levodopa-induced dyskinesias (LID). In particular, M4 muscarinic receptor (M4R) positive allosteric modulators (PAMs) are administered to reduce dyskinetic behavior.
Claims18
A method of treating a psychomotor disease comprising co-administering levodopa and a 4 muscarinic receptor (M4R) positive allosteric modulator (PAM) to a subject.
A method of treating levodopa-induced dyskinesias (LID) in a subject being treated with levodopa comprising administering an M4R PAM.
A pharmaceutical composition comprising levodopa and an M4R PAM.
18-25. (canceled)
Dependencies are inferred from the claim text.